SCHEMBL6563589

SCHEMBL6563589

O=C(c1ccc(C#CCNc2ccccc2)cc1)c1cccnc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GALR3 O60755 1/20 0.50
RAB9A P51151 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
EGLN1 Q9GZT9 1/20 0.46
PLOD2 O00469 1/20 0.46
NAMPT P43490 4/20 0.46
VNN1 O95497 1/20 0.45
ALDH1A1 P00352 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KCNK3 O14649 1/20 0.43
CYP2A6 P11509 1/20 0.42
CYP2C9 P11712 1/20 0.42
CHRNB2 P17787 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP2C19 P33261 1/20 0.42
CHRNA4 P43681 1/20 0.42
LMNA P02545 1/20 0.42
HIF1A Q16665 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
CYP11B1 P15538 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7676492 0.88 CCNA2 (0.41) GALR3RAB9ATDP1NAMPTVNN1
SCHEMBL6563325 0.87 KMT2A (0.50) GALR3RAB9ATDP1EGLN1PLOD2
SCHEMBL6563676 0.80 NAMPT (0.42) GALR3RAB9ATDP1NAMPTALDH1A1
SCHEMBL6563532 0.80 ALDH1A1 (0.44) RAB9AEGLN1VNN1ALDH1A1L3MBTL1
SCHEMBL6564996 0.79 KMT2A (0.54) RAB9AEGLN1ALDH1A1L3MBTL1KCNK3
SCHEMBL29712676 0.79 CHRNB2 (0.66) EGLN1CYP2A6CYP2C9CHRNB2CYP2B6
SCHEMBL6565427 0.78 VNN1 (0.46) RAB9AEGLN1VNN1L3MBTL1KCNK3
SCHEMBL6563625 0.78 PRSS1 (0.43) RAB9AALDH1A1L3MBTL1LMNA
SCHEMBL29712728 0.77 SMN1; SMN2 (0.50) RAB9ATDP1EGLN1ALDH1A1LMNA
SCHEMBL6563737 0.75 EGLN1 (0.45) RAB9ATDP1EGLN1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140802-B1 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-03-17 EP disclosed